Skip to main content
10 décembre 2024: France’s MaaT Pharma presented early access data at ASH for its microbiome based treatment for GvHD – a formal study will read out early next year – BiotechTV (English only)
Media

10 décembre 2024: France’s MaaT Pharma presented early access data at ASH for its microbiome based treatment for GvHD – a formal study will read out early next year – BiotechTV (English only)

Date : 10/12/2024

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club